Objective: To compare in detail the severity of illness among patients carrying the variant in exon 1-14 and ORF15 of retinitis pigmentosa GTPase regulator (RPGR).

Methods: Systematic generation sequencing analysis of the data, Sanger sequencing validation and segregation analysis used to identify variants of a pathogen. detailed eye examination, including Electroretinograms, fundus photography, fundus autofluorescence and optical coherence tomography performed. statistical analysis, including adjustment for age and comparison, is based on the level of cross-sectional study to compare the severity of disease between the two groups RPGR variants variants.
Results: Sixty-two variants identified in RPGR in 86 patients from 77 unrelated families. Twenty-nine (37.7%) have the variant in RPGR-exons 1-14 (group 1) and 48 (62.3%) in RPGR-ORF15 (group 2).

Eighty-four patients were diagnosed with X-linked retinitis pigmentosa and only two patients with cone-rod dystrophy. LogMAR visual acuity increased by 0,035 and 0,022 each year on average in group 1 and group 2, respectively. Group 2 patients had visual acuity better with logMAR average difference 0.4378, significant after adjustment for age (P <0.01). Good value log (wide zone ellipsoid) or central retinal thickness was significantly correlated with a variant of the grouping after considering the effect of the variable age (P = 0.56 and 0.40, respectively). ball refractive errors did not differ significantly between the two groups of variants (P = 0.17).

Autofluorescence patterns including ring hyperfluorescent in the posterior pole, spread hyperfluorescence in the macular region, and autofluorescence macular fovea dark with or without hyperfluorescence. Age and the proportion of fundus autofluorescence patterns between the two groups of variants were significantly different (P <0.01).

Conclusion: Patients with a variant in exon 1-14 maintained visual acuity less than patients with ORF15 variants and deteriorate faster. However, the width of the zone ellipsoid, central retinal thickness and refraction were comparable between the two groups. Autofluorescence patterns and variants associated with age grouping.

Genotypic and phenotypic characteristics in Chinese patients with Bardet-Biedl syndrome

Objective: To investigate the complex and different phenotypes in seven Chinese patients diagnosed with Bardet-Biedl syndrome (BBS) and carrying pathogenic mutations.

Methods: Seventy-related BBS patients enrolled. medical history and their eyes examined, and a comprehensive clinical examination, such as fundus photography, optical coherence tomography, and medical imaging, performed. A panel specific enrichment hereditary eye disease based on exome-capture technology used to gather and strengthen the protein-coding regions of the genes targeted 441 hereditary eye disease, followed by high-throughput sequencing using Illumina HiSeq platform.

Results: All patients exhibited a major clinical phenotype BBS. BBS seven mutations found in five patients (BBS7 in two patients, BBS10 in two patients, BBS12 in one patient), for level detection of 71% (5/7). New rate for mutations known BBS is 5: 2.

ABO Antibody (Blood Group Antigen B)
V2552-20UG	NSJ Bioreagents	20 ug	EUR 153.3
Description: The antibody HEB-20 reacts with human blood group B. The specificity of the antibody HEB-20 was confirmed by comparison of specificity and reactivity to standard reagent using >5.000 samples of blood. The mAb HEB-20 shows specific staining of erythrocytes and vascular epithelium of blood group B controls and no staining in group A controls. This mAb is applicable for tissue staining in tumor patients with blood groups B and AB. Blood group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

ABO Antibody (Blood Group Antigen B)
V2552IHC-7ML	NSJ Bioreagents	7 ml	EUR 349.3
Description: The antibody HEB-20 reacts with human blood group B. The specificity of the antibody HEB-20 was confirmed by comparison of specificity and reactivity to standard reagent using >5.000 samples of blood. The mAb HEB-20 shows specific staining of erythrocytes and vascular epithelium of blood group B controls and no staining in group A controls. This mAb is applicable for tissue staining in tumor patients with blood groups B and AB. Blood group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

ABO Antibody (Blood Group Antigen B)
V2552SAF-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: The antibody HEB-20 reacts with human blood group B. The specificity of the antibody HEB-20 was confirmed by comparison of specificity and reactivity to standard reagent using >5.000 samples of blood. The mAb HEB-20 shows specific staining of erythrocytes and vascular epithelium of blood group B controls and no staining in group A controls. This mAb is applicable for tissue staining in tumor patients with blood groups B and AB. Blood group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

anti-B human blood group antigen IgM
140-A-01mg	Virogen	0,1 mg	EUR 321
Description: anti-B human blood group antigen IgM

anti-B human blood group antigen IgM
140-A-1000ug	Virogen	1000 ug	EUR 1539
Description: anti-B human blood group antigen IgM

Blood group antigen B(HEB-29) Antibody
BNC941065-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF594 conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC941065-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF594 conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC801065-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF680 conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC801065-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF680 conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC811065-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF680R conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC811065-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF680R conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC701065-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF770 conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC701065-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF770 conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC881065-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF488A conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC881065-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF488A conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC051065-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF405M conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC051065-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF405M conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC041065-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF405S conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC041065-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF405S conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC401065-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF640R conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC401065-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF640R conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNCB1065-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood group antigen B(HEB-29), Biotin conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNCB1065-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood group antigen B(HEB-29), Biotin conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNCAP1065-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood group antigen B(HEB-29), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNCAP1065-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood group antigen B(HEB-29), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNCA1065-250	Biotium	250uL	EUR 459.6
Description: Primary antibody against Blood group antigen B(HEB-29), APC conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNCR1065-250	Biotium	250uL	EUR 459.6
Description: Primary antibody against Blood group antigen B(HEB-29), RPE conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNCP1065-250	Biotium	250uL	EUR 459.6
Description: Primary antibody against Blood group antigen B(HEB-29), PerCP conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNUM1065-50	Biotium	50uL	EUR 474
Description: Primary antibody against Blood group antigen B(HEB-29), 1mg/mL

Blood group antigen B(HEB-29) Antibody
BNCH1065-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood group antigen B(HEB-29), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNCH1065-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood group antigen B(HEB-29), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNUB1065-100	Biotium	100uL	EUR 250.8
Description: Primary antibody against Blood group antigen B(HEB-29), Concentration: 0.2mg/mL

Blood group antigen B(HEB-29) Antibody
BNUB1065-500	Biotium	500uL	EUR 549.6
Description: Primary antibody against Blood group antigen B(HEB-29), Concentration: 0.2mg/mL

Blood group antigen B(HEB-29) Antibody
BNC611065-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF660R conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC611065-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF660R conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC551065-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF555 conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC551065-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF555 conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC431065-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF543 conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC431065-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF543 conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC681065-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF568 conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC681065-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF568 conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC471065-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF647 conjugate, Concentration: 0.1mg/mL

Blood group antigen B(HEB-29) Antibody
BNC471065-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood group antigen B(HEB-29), CF647 conjugate, Concentration: 0.1mg/mL

Anti-Human blood group antigen B antibody
STJ16100162	St John's Laboratory	1 mL	EUR 382.8

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNCA0296-250	Biotium	250uL	EUR 459.6
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), APC conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC800296-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF680 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC800296-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF680 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC810296-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF680R conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC810296-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF680R conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC940296-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF594 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC940296-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF594 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC700296-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF770 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC700296-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF770 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC430296-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF543 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC430296-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF543 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC400296-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF640R conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC400296-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF640R conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC050296-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF405M conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC050296-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF405M conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNCB0296-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), Biotin conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNCB0296-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), Biotin conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNCAP0296-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNCAP0296-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC880296-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF488A conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC880296-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF488A conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNCR0296-250	Biotium	250uL	EUR 459.6
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), RPE conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNCP0296-250	Biotium	250uL	EUR 459.6
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), PerCP conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNUM0296-50	Biotium	50uL	EUR 474
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), 1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNCH0296-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNCH0296-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNUB0296-100	Biotium	100uL	EUR 250.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), Concentration: 0.2mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNUB0296-500	Biotium	500uL	EUR 549.6
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), Concentration: 0.2mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC040296-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF405S conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC040296-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF405S conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC550296-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF555 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC550296-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF555 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC610296-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF660R conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC610296-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF660R conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC680296-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF568 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC680296-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF568 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC470296-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF647 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen B (CD173) (HEB-20) Antibody
BNC470296-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen B (CD173)(HEB-20), CF647 conjugate, Concentration: 0.1mg/mL

Blood Group H ab Antigen antibody
10R-H103a	Fitzgerald	100 ug	EUR 327.6
Description: Mouse monoclonal Blood Group H ab Antigen antibody

ABO Antibody (Blood Group Antigen A)
V2549-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: This antibody recognizes human blood group A (monofucosyl and difucosyl A antigens with chain types 1, 2, 3, 4, 5, 6) and Forssmann antigen. It is also reactive with the immuno-dominant A trisaccharide. Blood group antigen expression in human colon cancer was studied by means of two monoclonal antibodies of broad anti-A (HE-14) and anti-type 3 and type 4 chain-based A and H (HE-10) specificity. These antigens were proved to re-appear in tumors of the distal colon, the HE-10 antibody reacting more frequently (9 out of 12 samples) than HE-14 (5 out of 12 samples) and frequently with supra-nuclear staining of the cytoplasm probably in those places of the Golgi apparatus where carbohydrate antigens are synthesized. This staining pattern is characteristic of HE-10 in normal colonic mucosa as well. With HE-14, staining was often absent in less differentiated tumors, while HE-10 did react in such tumors. In some cases, these two antibodies gave different staining patterns in parallel sections from the same tissue sample, primarily at the cellular level. Three out of 12 cases showed blood group antigen expression in the mucosa of the distal colon adjacent to the tumor only when HE-10 mAb was used.

ABO Antibody (Blood Group Antigen A)
V2549-20UG	NSJ Bioreagents	20 ug	EUR 153.3
Description: This antibody recognizes human blood group A (monofucosyl and difucosyl A antigens with chain types 1, 2, 3, 4, 5, 6) and Forssmann antigen. It is also reactive with the immuno-dominant A trisaccharide. Blood group antigen expression in human colon cancer was studied by means of two monoclonal antibodies of broad anti-A (HE-14) and anti-type 3 and type 4 chain-based A and H (HE-10) specificity. These antigens were proved to re-appear in tumors of the distal colon, the HE-10 antibody reacting more frequently (9 out of 12 samples) than HE-14 (5 out of 12 samples) and frequently with supra-nuclear staining of the cytoplasm probably in those places of the Golgi apparatus where carbohydrate antigens are synthesized. This staining pattern is characteristic of HE-10 in normal colonic mucosa as well. With HE-14, staining was often absent in less differentiated tumors, while HE-10 did react in such tumors. In some cases, these two antibodies gave different staining patterns in parallel sections from the same tissue sample, primarily at the cellular level. Three out of 12 cases showed blood group antigen expression in the mucosa of the distal colon adjacent to the tumor only when HE-10 mAb was used.

ABO Antibody (Blood Group Antigen A)
V2549SAF-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: This antibody recognizes human blood group A (monofucosyl and difucosyl A antigens with chain types 1, 2, 3, 4, 5, 6) and Forssmann antigen. It is also reactive with the immuno-dominant A trisaccharide. Blood group antigen expression in human colon cancer was studied by means of two monoclonal antibodies of broad anti-A (HE-14) and anti-type 3 and type 4 chain-based A and H (HE-10) specificity. These antigens were proved to re-appear in tumors of the distal colon, the HE-10 antibody reacting more frequently (9 out of 12 samples) than HE-14 (5 out of 12 samples) and frequently with supra-nuclear staining of the cytoplasm probably in those places of the Golgi apparatus where carbohydrate antigens are synthesized. This staining pattern is characteristic of HE-10 in normal colonic mucosa as well. With HE-14, staining was often absent in less differentiated tumors, while HE-10 did react in such tumors. In some cases, these two antibodies gave different staining patterns in parallel sections from the same tissue sample, primarily at the cellular level. Three out of 12 cases showed blood group antigen expression in the mucosa of the distal colon adjacent to the tumor only when HE-10 mAb was used.

ABO Antibody (Blood Group Antigen A)
V2550-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: This antibody recognizes human blood group A (monofucosyl and difucosyl A antigens with chain types 1, 2, 3, 4, 5, 6) and Forssmann antigen. Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

ABO Antibody (Blood Group Antigen A)
V2550-20UG	NSJ Bioreagents	20 ug	EUR 153.3
Description: This antibody recognizes human blood group A (monofucosyl and difucosyl A antigens with chain types 1, 2, 3, 4, 5, 6) and Forssmann antigen. Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

ABO Antibody (Blood Group Antigen A)
V2550SAF-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: This antibody recognizes human blood group A (monofucosyl and difucosyl A antigens with chain types 1, 2, 3, 4, 5, 6) and Forssmann antigen. Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

ABO Antibody (Blood Group Antigen A)
V2553-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: This mAb preferably reacts with determinants of chain A and H type 3 (Gal1-3GalNAc-R) and 4 (Gal1-3GalNAc-R), but not with type 1 and 2 chain structures. It is not reactive with immuno-dominant A trisaccharide. This mAb is applicable for tissue staining in tumor patients with blood groups A and AB. It shows a highly heterogeneous reactivity in human colon tumor tissue and adjacent mucosa. Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

ABO Antibody (Blood Group Antigen A)
V2553-20UG	NSJ Bioreagents	20 ug	EUR 153.3
Description: This mAb preferably reacts with determinants of chain A and H type 3 (Gal1-3GalNAc-R) and 4 (Gal1-3GalNAc-R), but not with type 1 and 2 chain structures. It is not reactive with immuno-dominant A trisaccharide. This mAb is applicable for tissue staining in tumor patients with blood groups A and AB. It shows a highly heterogeneous reactivity in human colon tumor tissue and adjacent mucosa. Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

ABO Antibody (Blood Group Antigen A)
V2553SAF-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: This mAb preferably reacts with determinants of chain A and H type 3 (Gal1-3GalNAc-R) and 4 (Gal1-3GalNAc-R), but not with type 1 and 2 chain structures. It is not reactive with immuno-dominant A trisaccharide. This mAb is applicable for tissue staining in tumor patients with blood groups A and AB. It shows a highly heterogeneous reactivity in human colon tumor tissue and adjacent mucosa. Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

ABO Antibody (Blood Group Antigen A)
V2554-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: This mAb preferably reacts with determinants of chain A and H type 3 (Gal1-3GalNAc-R) and 4 (Gal1-3GalNAc-R), but not with type 1 and 2 chain structures. It is not reactive with immuno-dominant A trisaccharide. This mAb is applicable for tissue staining in tumor patients with blood groups A and AB. It shows a highly heterogeneous reactivity in human colon tumor tissue and adjacent mucosa. Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

ABO Antibody (Blood Group Antigen A)
V2554-20UG	NSJ Bioreagents	20 ug	EUR 153.3
Description: This mAb preferably reacts with determinants of chain A and H type 3 (Gal1-3GalNAc-R) and 4 (Gal1-3GalNAc-R), but not with type 1 and 2 chain structures. It is not reactive with immuno-dominant A trisaccharide. This mAb is applicable for tissue staining in tumor patients with blood groups A and AB. It shows a highly heterogeneous reactivity in human colon tumor tissue and adjacent mucosa. Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

ABO Antibody (Blood Group Antigen A)
V2554IHC-7ML	NSJ Bioreagents	7 ml	EUR 349.3
Description: This mAb preferably reacts with determinants of chain A and H type 3 (Gal1-3GalNAc-R) and 4 (Gal1-3GalNAc-R), but not with type 1 and 2 chain structures. It is not reactive with immuno-dominant A trisaccharide. This mAb is applicable for tissue staining in tumor patients with blood groups A and AB. It shows a highly heterogeneous reactivity in human colon tumor tissue and adjacent mucosa. Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

ABO Antibody (Blood Group Antigen A)
V2554SAF-100UG	NSJ Bioreagents	100 ug	EUR 349.3
Description: This mAb preferably reacts with determinants of chain A and H type 3 (Gal1-3GalNAc-R) and 4 (Gal1-3GalNAc-R), but not with type 1 and 2 chain structures. It is not reactive with immuno-dominant A trisaccharide. This mAb is applicable for tissue staining in tumor patients with blood groups A and AB. It shows a highly heterogeneous reactivity in human colon tumor tissue and adjacent mucosa. Blood-group antigens are generally defined as molecules formed by sequential addition of saccharides to the carbohydrate side chains of lipids and proteins detected on erythrocytes and certain epithelial cells. The A, B and H antigens are reported to undergo modulation during malignant cellular transformation. Blood group related antigens represent a group of carbohydrate determinants carried on both glycolipids and glycoproteins. They are usually mucin-type, and are detected on erythrocytes, certain epithelial cells, and in secretions of certain individuals. Sixteen genetically and biosynthetically distinct but inter-related specificities belong to this group of antigens, including A, B, H, Lewis A, Lewis B, Lewis X, Lewis Y, and precursor type 1 chain antigens.

Monoclonal Blood Group Antigen Lewis B Antibody, Clone: SPM194
AMM00726G	Leading Biology	7 ml	EUR 580.8
Description: A Monoclonal antibody against Human Blood Group Antigen Lewis B. The antibodies are raised in Mouse and are from clone SPM194. This antibody is applicable in IHC, IF

Rh Blood Group D Antigen (RHD) Antibody
20-abx318000	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Rh Blood Group, D Antigen (RHD) Antibody
20-abx174400	Abbexa	EUR 1111.20 EUR 560.40	1 mg 200 ug

Rh Blood Group D Antigen (RHD) Antibody
abx029359-400ul	Abbexa	400 ul	EUR 627.6

Rh Blood Group D Antigen (RHD) Antibody
abx029359-80l	Abbexa	80 µl	EUR 343.2

Rh Blood Group, D Antigen (RHD) Antibody
20-abx132208	Abbexa	EUR 543.60 EUR 159.60 EUR 1579.20 EUR 744.00 EUR 410.40	100 ug 10 ug 1 mg 200 ug 50 ug

Rh Blood Group D Antigen (RHD) Antibody
20-abx323345	Abbexa	EUR 376.80 EUR 292.80	100 ug 50 ug

Blood Group Antigen A (CD173) (33C13) Antibody
BNC941261-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF594 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC941261-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF594 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC801261-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF680 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC801261-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF680 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC811261-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF680R conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC811261-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF680R conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC701261-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF770 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC701261-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF770 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC881261-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF488A conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC881261-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF488A conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC051261-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF405M conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC051261-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF405M conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC041261-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF405S conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC041261-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF405S conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC401261-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF640R conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC401261-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF640R conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNCB1261-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), Biotin conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNCB1261-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), Biotin conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNCAP1261-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNCAP1261-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNCA1261-250	Biotium	250uL	EUR 459.6
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), APC conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNCR1261-250	Biotium	250uL	EUR 459.6
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), RPE conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNCP1261-250	Biotium	250uL	EUR 459.6
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), PerCP conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNUM1261-50	Biotium	50uL	EUR 474
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), 1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNCH1261-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNCH1261-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNUB1261-100	Biotium	100uL	EUR 250.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), Concentration: 0.2mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNUB1261-500	Biotium	500uL	EUR 549.6
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), Concentration: 0.2mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC611261-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF660R conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC611261-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF660R conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC551261-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF555 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC551261-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF555 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC431261-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF543 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC431261-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF543 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC681261-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF568 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC681261-500	Biotium	500uL	EUR 652.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF568 conjugate, Concentration: 0.1mg/mL

Blood Group Antigen A (CD173) (33C13) Antibody
BNC471261-100	Biotium	100uL	EUR 238.8
Description: Primary antibody against Blood Group Antigen A (CD173)(33C13), CF647 conjugate, Concentration: 0.1mg/mL

Conclusion: This study shows the spectrum of phenotypic and genotypic BBS patients from China, and the findings underscore the importance of obtaining a comprehensive clinical observations and molecular analyzes to ciliopathies.